Objective-To assess the outcome of arterial duct occlusion with coils chosen according to the duct morphology. Design-Retrospective study. Setting-Paediatric cardiology centre. Patients-Coil occlusion was attempted in 57 patients aged 0 5 to 15 (median 3.7) years and weighing 5-59 (median 14) kg between January 1991 and December 1995. A residual leak was present in 8 patients after umbrella closure and in 4 patients after duct ligation. Methods-Coils of 4 different types were implanted through 4 or 5 F femoral artery catheters. Platinum or Interlocking Detachable 0-018 inch coils were deployed completely inside tubular ducts. Gianturco or PDA controlled release 0-038 inch coils were implanted to straddle short, post ligation and post umbrella ducts. Results-Coil implantation was successful in 54/57 patients. At 1 year the cumulative occlusion rate was 53/57 ducts (93%) on an intention to treat analysis. A single coil was implanted in 37 (69%), 2 coils in 10 (19%), 3 coils in 3 (5%) and 4 coils in 4 (7%) of the 54 successful procedures.
Transcatheter occlusion of the arterial duct using Rashkind umbrellas is now standard practice in most European paediatric cardiology centres.1 Deployment into small arterial ducts, however, can be difficult and strategies such as balloon or serial catheter dilatation of the duct or creation of an arteriovenous guidewire circuit are often required.2 These add to the complexity of the procedure. A residual leak is present in up to 10-20% of ducts though the incidence falls with time. 3 Implantation of a second device is possible,4 though if the residual leak is small, this may also be difficult. In small infants implantation of a Rashkind device may not be possible because of the size of the delivery system and the device itself.5 6 In the USA, where the Rashkind device originated, its use has been restricted because of regulatory issues. More recently, Gianturco coils have been used as an alternative transcatheter approach. Several series have demonstrated their effectiveness for occluding small to moderate sized ducts with single or multiple coils during the same procedure.7 9 In our centre, coils were first implanted into the arterial duct in 1991. The technique and its evolution is described in this study.
Patients and methods

PATIENTS
Coil implantation was attempted in 57 patients aged 0 5 to 15 years (median 3-7 years) and weighing 5 to 59 kg (median 14 kg) between January 1991 and December 1995. Duct ligation had been performed previously in four patients, and in two of these a subsequent Rashkind umbrella implantation had failed. A Rashkind umbrella had been implanted in eight patients (12 mm Target Therapeutics) introduced through the 4 or 5F catheter was used to implant the coils entirely within the duct. The 0-038 inch coils were deployed by extruding 1-2 loops through the 4 or 5 F catheter into the pulmonary artery, withdrawing the extruded loops to the pulmonary artery orifice of the duct, and then withdrawing the catheter to deposit the remaining loops inside the duct and in the aortic ampulla. Additional coils were implanted if a significant leak remained.
At the end of the procedure a final aortogram was performed. Flucloxacillin and gentamicin were administered during the procedure and for the next 24 hours. The patients were discharged the following day after a colour flow Doppler study. Doppler studies were repeated at six weeks, six months, and one year.
CHOICE OF COIL
Coil implantation was initially attempted when the size and shape of the duct posed difficulties for simple implantation of a Rashkind umbrella. In addition, the duct shape was such that it was thought possible to implant the coil completely within the duct and avoid coil loops projecting into either the aorta or pulmonary artery. Thus in the early part of the series 0-018 inch platinum fibre coils were the most commonly used because the alternative was the stiffer Gianturco coils which were less suited to implantation inside the duct.
Subsequently, after evidence that implantation of coils with loops protruding into the aorta and pulmonary artery was safe,7-9 coil implantation was extended to ducts that could have been closed by implantation of a Rashkind umbrella. Initially only smaller ducts (narrowest diameter less than 2 mm) were attempted with coil diameters of at least twice the minimum diameter. With experience, larger ducts, in which more than one coil was required, were selected. Residual leaks after implantation of a Rashkind occluder also became eligible for this technique. The Gianturco coil was the initial coil of choice until the similar PDA coil, with its safety release mechanism, became available. For ducts where it was possible to implant the coils wholly inside the duct, the Interlocking Detachable Coil became the preferred coil. Table 1 shows the types of coil by year of implantation together with the concomitant decline in umbrella use.
ETHICAL CONSIDERATIONS
In the first cohort the occlusion procedure was identical to that used for embolising collateral arteries and other vessels'0 and was potentially simpler than Rashkind umbrella implantation and was indicated clinically. In the second era the straddling coil technique had already become established and reported7-9 and ethical permission was therefore unnecessary.
Results
Implantation was successful in 54 of the 57 patients. In one patient the coil embolised and 
*Excludes three patients in whom coil implantation was not successful.
was not replaced. In two patients the coil was deployed but removed because of complications (see later). One coil was implanted in 37 (69%), two coils in 10 (19%), three coils in three (5%), and four coils in four (7%). In the last 17 patients 4 F sheaths and catheters were used in the femoral artery. There were no arterial complications. The time course of duct occlusion is shown in tables 2 and 3. The cumulative occlusion rate was 93% (53/57) at one year on an intention to treat analysis and 98% (53/54) for successful implantations.
199 Coil implantation into long tubular ducts was successful in three of four patients with 0-018 inch platinum fibre coils (1-3 coils per patient) with complete occlusion ( Post duct ligation-In four patients the duct was occluded with one or two Gianturco or PDA coils (fig 3) ; at the end of the procedure in two (50%) and by the following day in the other two (50%) patients (table 3) .
Previous Rashkind umbrella procedure-Coil implantation was successful in seven of eight patients. In one patient with a mild recoarctation the Gianturco coil increased the gradient in the aorta and was removed. A single Gianturco or PDA coil (fig 4) was implanted in five patients, three PDA coils were implanted in one patient, and a single Interlocking Detachable Coil was implanted in one patient. The duct was occluded at angiography in one (14%), by the following day in a further three (43%), and at six months in two (28%) more patients (table 3) . In one patient with a PDA coil and a previous Rashkind umbrella procedure the duct was still patent at one year. Discussion A transcatheter approach is now the method of choice for duct occlusion in many paediatric cardiology centres.' 3 The Ivalon plug was the first effective technique but was limited because the large bore arterial sheaths often needed surgical access to the femoral artery." The Rashkind device, which is usually implanted through the venous route, extended the application to smaller children and infants. ' Occlusion rates are reported to be as high as 90% after use of one or more Gianturco coils. 8 9 In our experience, on an intention to treat basis, the occlusion rate was 93% (53/57). When it was possible to implant coils completely within the duct, the success rate was 100% (9/9) with 56% (5/9) occluded by six weeks and the remainder by one year. When coils were used to straddle the duct the occlusion rate was 86% (6/7) for post umbrella ducts with one duct not occluded at one year, 100% (4/4) for post ligation ducts, and 100% (34/34) for native ducts.
EMBOLISATION
In the first cohort the coil embolised in two out of four patients. This reflected both our inexperience in judging the correct size and type of coil and a goal of depositing the entire coil completely inside the duct. Implanting the coil so as to straddle the duct from the pulmonary artery to the aorta has considerably reduced the incidence of embolisation. In this role, the Gianturco coil, when of a sufficient size, is effective in occluding the duct with a low risk of embolisation. The similar PDA coil further reduces the likelihood of embolisation because its screw attachment allows it to be removed or repositioned before release if it is deployed in a suboptimal position. For implantation inside long tubular ducts the Interlocking Detachable Coil has also reduced the incidence of displacement. Though these measures will reduce the incidence of embolisation and the attendant increased fluoroscopy time, sporadic embolisation will still occur and equipment for retrieval and experience in its use is mandatory.7
ROUTE OF COIL IMPLANTATION
We and others have implanted the coil through an arterial catheter.79 A case has been 529 a .-A group.bmj.com on June 21, 2017 -Published by http://heart.bmj.com/ Downloaded from made for implantation from the venous side8 but we do not see any advantage. Aortography is required before, during, and after implantation so that arterial cannulation is required even when the venous approach is used. If coils are deposited entirely within the duct there is no need to cross the narrowest point at the pulmonary end before coil implantation. The use of 4 F catheters with a 0-038 inch lumen for coil implantation will also reduce the risk of arterial occlusion. Even with the 5 F catheters we have not had arterial complications.
NUMBER OF COILS
In one patient in whom a single coil was implanted the coil was removed because of haemolysis. This was early in our experience with larger ducts and we were aware of a significant shunt at the end of the procedure. In a similar situation we would now place as many as four coils at the same procedure.8 This applies also to the only patient with a leak one year after coil implantation in whom a significant shunt was present at the end of the procedure. We have not observed any gradients in either the aorta or pulmonary artery after implanting three or four straddling coils.
Our experience suggests that coil implantation is an effective and safe method for duct occlusion when coils of various types are selected according to the duct morphology. 
